T1	DISO 71 87	colitis ulcerosa
#1	AnnotatorNotes T1	C0009324; Ulcerative Colitis; Disease or Syndrome
T2	CHEM 117 133	inhibidor de TNF
T3	CHEM 314 323	BI 655130
T4	DISO 162 187	inflamación del intestino
T5	CHEM 219 228	BI 655130
T6	PROC 242 249	terapia
#2	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	PROC 280 310	Estudio preliminar de eficacia
T8	PROC 329 340	tratamiento
#3	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	DISO 368 384	colitis ulcerosa
#4	AnnotatorNotes T9	C0009324; Ulcerative Colitis; Disease or Syndrome
T10	DISO 1254 1283	Tuberculosis activa o latente
#5	AnnotatorNotes T10	C0151332; Active tuberculosis; Disease or Syndrome + C1609538; Latent Tuberculosis; Disease or Syndrome
T11	PROC 422 433	tratamiento
#6	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	CHEM 438 456	inhibidores de TNF
T13	DISO 481 497	Colitis ulcerosa
#7	AnnotatorNotes T13	C0009324; Ulcerative Colitis; Disease or Syndrome
T14	DISO 524 540	Colitis ulcerosa
#8	AnnotatorNotes T14	C0009324; Ulcerative Colitis; Disease or Syndrome
T15	PROC 577 584	terapia
#9	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	CHEM 589 607	inhibidores de TNF
T17	PROC 687 701	aleatorización
#10	AnnotatorNotes T17	C0034656; Randomization; Research Activity
T18	PROC 704 715	Diagnóstico
#11	AnnotatorNotes T18	C0011900; Diagnosis; Diagnostic Procedure
T19	DISO 719 735	colitis ulcerosa
#12	AnnotatorNotes T19	C0009324; Ulcerative Colitis; Disease or Syndrome
T20	PROC 769 780	tratamiento
#13	AnnotatorNotes T20	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T21	CHEM 785 803	inhibidores de TNF
T22	PROC 860 874	aleatorización
#14	AnnotatorNotes T22	C0034656; Randomization; Research Activity
T23	DISO 911 921	enfermedad
#15	AnnotatorNotes T23	C0012634; Disease; Disease or Syndrome
T24	CHEM 1082 1098	inhibidor de TNF
T25	CHEM 1101 1112	vedolizumab
#16	AnnotatorNotes T25	C2742797; vedolizumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T26	PROC 1115 1142	Resección extensa del colon
T27	ANAT 1137 1142	colon
#17	AnnotatorNotes T27	C0009368; Colon structure; Body Part, Organ, or Organ Component | C1281569; Entire colon; Body Part, Organ, or Organ Component
T28	DISO 1159 1212	infección con C. difficile u otro patógeno intestinal
#18	AnnotatorNotes T28	C0343386; Clostridium difficile infection; Disease or Syndrome + C0178238; Intestinal infectious disease; Disease or Syndrome
T29	ANAT 1202 1212	intestinal
#19	AnnotatorNotes T29	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T30	ANAT 178 187	intestino
#20	AnnotatorNotes T30	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T31	Date 13 17	2016
T32	LIVB 57 66	pacientes
#21	AnnotatorNotes T32	C0030705; Patients; Patient or Disabled Group
T34	LIVB 205 213	paciente
#22	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T35	Date 250 256	actual
T36	LIVB 354 363	pacientes
#23	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group
T37	Age 636 654	Entre 18 y 60 años
T38	Duration 739 758	los últimos 4 meses
T39	Duration 828 847	los últimos 4 meses
T41	Duration 1213 1229	al menos 28 días
T42	LIVB 1193 1201	patógeno
#24	AnnotatorNotes T42	C0450254; Pathogenic organism; Organism
T33	Dose 808 824	dosis constantes
T40	LIVB 1173 1185	C. difficile
#25	AnnotatorNotes T40	C0079134; Clostridium difficile; Bacterium
A1	Status T24 History_of
A2	Status T25 History_of
A3	Status T26 History_of
#26	AnnotatorNotes T2	C3537192; Tumor Necrosis Factor Inhibitors; Pharmacologic Substance 
#27	AnnotatorNotes T16	C3537192; Tumor Necrosis Factor Inhibitors; Pharmacologic Substance 
#28	AnnotatorNotes T12	C3537192; Tumor Necrosis Factor Inhibitors; Pharmacologic Substance 
#29	AnnotatorNotes T21	C3537192; Tumor Necrosis Factor Inhibitors; Pharmacologic Substance 
#30	AnnotatorNotes T24	C3537192; Tumor Necrosis Factor Inhibitors; Pharmacologic Substance 
#31	AnnotatorNotes T5	C5543835; BI 655130; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor 
#32	AnnotatorNotes T3	C5543835; BI 655130; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor 
#33	AnnotatorNotes T35	C0521116; Current (present time); Temporal Concept 
R1	Experiences Arg1:T32 Arg2:T1	
T43	CONC 956 966	Mayo (MCS)
#34	AnnotatorNotes T43	C5420651; Ulcerative Colitis Disease Activity Index; Intellectual Product
T44	Result_or_Value 968 986	menor o igual a 10
R2	Has_Result_or_Value Arg1:T43 Arg2:T44	
T45	Quantifier_or_Qualifier 88 103	leve o moderada
#35	AnnotatorNotes T45	C1299392; Mild to moderate; Qualitative Concept
R3	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T45	
T48	Observation 877 886;896 904	Actividad moderada
#38	AnnotatorNotes T48	C3833417; Moderate activity; Finding
R5	Overlap Arg1:T19 Arg2:T38	
R6	Overlap Arg1:T18 Arg2:T38	
T49	Quantifier_or_Qualifier 544 550	ligera
R7	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T49	
R8	Used_for Arg1:T16 Arg2:T15	
T50	PROC 675 684	selección
#39	AnnotatorNotes T50	C0242802; Patient Selection; Research Activity
R9	Overlap Arg1:T50 Arg2:T37	
R10	Overlap Arg1:T17 Arg2:T37	
R11	Experiences Arg1:T32 Arg2:T2	
R12	Location_of Arg1:T30 Arg2:T4	
R13	Experiences Arg1:T34 Arg2:T5	
R14	Experiences Arg1:T34 Arg2:T4	
R15	Experiences Arg1:T34 Arg2:T6	
R16	Combined_with Arg1:T5 Arg2:T6	
R17	Overlap Arg1:T6 Arg2:T35	
T51	Observation 188 194	mejora
#40	AnnotatorNotes T51	C0184511; Improved; Finding (?)
R18	Used_for Arg1:T3 Arg2:T8	
R19	Experiences Arg1:T36 Arg2:T3	
R20	Experiences Arg1:T36 Arg2:T9	
T52	Quantifier_or_Qualifier 395 410	leve a moderada
#41	AnnotatorNotes T52	C1299392; Mild to moderate; Qualitative Concept 
T53	Observation 877 893	Actividad ligera
R21	Used_for Arg1:T21 Arg2:T20	
R22	Has_Dose_or_Strength Arg1:T21 Arg2:T33	
T54	Quantifier_or_Qualifier 1063 1072	más de un
R23	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T54	
R24	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T54	
#42	AnnotatorNotes T49	C2945599; Mild (qualifier value); Qualitative Concept (?)
T55	Quantifier_or_Qualifier 553 573	moderadamente activa
R25	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T55	
#43	AnnotatorNotes T55	C0205081; Moderate (severity modifier); Qualitative Concept
R26	Overlap Arg1:T21 Arg2:T39	
R27	Before Arg1:T20 Arg2:T22	
R28	Location_of Arg1:T27 Arg2:T26	
R29	Causes Arg1:T40 Arg2:T28	
R30	Causes Arg1:T42 Arg2:T28	
R31	Location_of Arg1:T29 Arg2:T28	
R32	Has_Duration_or_Interval Arg1:T28 Arg2:T41	
T56	PROC 1242 1251	selección
#44	AnnotatorNotes T56	C0242802; Patient Selection; Research Activity
R33	Before Arg1:T28 Arg2:T56	
R34	Experiences Arg1:T34 Arg2:T51	
R35	Before Arg1:T5 Arg2:T51	
R36	Before Arg1:T4 Arg2:T51	
R37	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T52	
R39	Combined_with Arg1:T3 Arg2:T11	
R40	Used_for Arg1:T12 Arg2:T11	
T57	Quantifier_or_Qualifier 385 391	activa
#45	AnnotatorNotes T57	C0679217; Active State; Idea or Concept
R41	Has_Quantifier_or_Qualifier Arg1:T9 Arg2:T57	
T46	Spec_cue 156 158	si
A4	Assertion T51 Speculated
R4	Speculation Arg1:T46 Arg2:T51	
R38	Experiences Arg1:T36 Arg2:T11	
#36	AnnotatorNotes T4	C5569080; Enteritis of intestine; Disease or Syndrome
#37	AnnotatorNotes T26	C4763870; Colon Resection; Therapeutic or Preventive Procedure (?)
A5	Experiencer T32 Patient
A6	Experiencer T34 Patient
A7	Experiencer T36 Patient
